Patrícia Puccinelli Orlandi

Patrícia Puccinelli Orlandi

Auto-generated profile, based on publicly available information

Patrícia Puccinelli Orlandi

Laboratório de Diagnóstico e controle de doenças infecciosas na amazônia (DCDIA), Instituto Leônidas & Maria Deane, Fiocruz Amazônia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Arquivos de Gastroenterologia
Verified
Journal Article
Open access
PDF file
RTRoger Lafontaine Mesquita Taborda
Roger Lafontaine Mesquita Taborda
LSLuiz Antônio da Silva
Luiz Antônio da Silva
POPatrícia Orlandi
Patrícia Orlandi
FBFlávia Serrano Batista
Flávia Serrano Batista
RRRenata Santos Rodrigues
Renata Santos Rodrigues
NMNajla Benevides Matos
Najla Benevides Matos
BACKGROUND: Enteroaggregative Escherichia coli (EAEC) is one of the main acute and chronic diarrhea causes both in children and adults, mainly in developing countries. OBJECTIVE: The aim of the present study is to characterize EAEC strains isolated from faecal samples and to identify genes potentially contributing to virulence, biofilm production and antimicrobial resistance in children admitted to a pediatric hospital in Porto Velho, Rondônia State. METHODS: The total of 1,625 E. coli specimens were isolated from 591 children in the age group 6 years or younger who were hospitalized in Cosme and Damião Children Hospital in Porto Velho, between February 2010 and February 2012, with acute gastroenteritis. Colonies suggestive of E. coli were subjected to polymerase chain reaction testing in order to identify the virulence factors. The in vitro adhesion assays using HEp-2 adherence were tests. Biofilm detection through spectrophotometry and antimicrobial susceptibility tests were conducted in the disk diffusion method. RESULTS: The mentioned study examined 591 stool samples from children with diarrhea. Diarrheogenic E. coli was found in 27.4% (162/591) of the children. EAEC was the diarreagenic E. coli most frequently associated with diarrhea 52.4% (85/162), which was followed by enteropathogenic E. coli 43.8% (71/162), enterotoxigenic E. coli 2.4% (4/162), and enterohemorrhagic E. coli 1.2% (2/162). The aggR gene was detected in 63.5% (54/85) of EAEC isolates; moreover, statistically significant correlation was observed among typical EAEC (aggR) and aatA (P<0.0001), irp2 (P=0.0357) and shf (P=0.0328). It was recorded that 69% (59/85) of the 85 analyzed EAEC strains were biofilm producers; 73% (43/59) of the biofilm producers carried the aggR gene versus 42.3% (11/26) of non-producers (P=0.0135). In addition, there was association between the aatA gene and biofilm production; 61% (36/59) of the samples presented producer strains, versus 19.2% (5/26) of non-producers (P<0.0004). Antibiotic sensitivity test evidenced that most EAEC were ampicillin 70.6% (60/85), sulfamethoxazole 60% (51/85), tetracycline 44.7% (38/85) and cefotaxime 22.4% (19/85) resistant. CONCLUSION: As far as it is known, the present study is pioneer in Northern Brazil to investigate EAEC virulence factors and to show the antimicrobial susceptibility of EAEC strains isolated from children with diarrhea.

1 October 2021 in Revista Brasileira de Farmacognosia
Verified
Journal Article
Closed access
PDF file
KFKamila Rangel Primo Fernandes
Kamila Rangel Primo Fernandes
ASAntonia Queiroz Lima de Souza
Antonia Queiroz Lima de Souza
LSLane Alencar dos Santos
Lane Alencar dos Santos
FNFábio Nogueira
Fábio Nogueira
JEJoseph Albert Medeiros Evaristo
Joseph Albert Medeiros Evaristo
POPatrícia Orlandi
Patrícia Orlandi

31 July 2019 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
PDF file
GBGlaucia Cristina Manço da Costa Bolson
Glaucia Cristina Manço da Costa Bolson
IBIuri Bezerra de Barros
Iuri Bezerra de Barros
CVCecília Volkmer‐Ribeiro
Cecília Volkmer‐Ribeiro
JLJosélia Lima
Josélia Lima
TFTanos Franca
Tanos Franca
Valdir Florencio Veiga-JuniorValdir Florencio Veiga-Junior
Valdir Florencio Veiga-Junior

1 January 2025 in International Journal of Biomaterials
Verified
Journal Article
Open access
TFTaisa Farias
Taisa Farias
IBIvanildes Bastos
Ivanildes Bastos
JRJoelma Cavalcante Ricardo
Joelma Cavalcante Ricardo
JCJessica F. Cunha
Jessica F. Cunha
Yonny Romaguera BarcelayYonny Romaguera Barcelay
Yonny Romaguera Barcelay
Walter Ricardo BritoWalter Ricardo Brito
Walter Ricardo Brito
This study focuses on developing and characterizing electrospun polycaprolactone (PCL) membranes as scaffolds for cell growth, leveraging their ability to mimic the extracellular matrix and promote cell proliferation. The membranes were fabricated by electrospinning and sterilized using ozone at room temperature. Comprehensive characterization techniques, including scanning electron microscopy (SEM), contact angle measurements, ultraviolet–visible spectroscopy (UV–Vis), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), Fourier transform infrared (FTIR) spectroscopy, Raman spectroscopy, and in vitro biocompatibility assays with MRC‐5 cells, were employed. The electrospun membranes exhibited uniform fibers with an average diameter of 403 ± 100 nm and demonstrated sterility, with no microbial growth observed after incubation. Contact angle measurements revealed values of 123 ± 0.42° and 123 ± 0.25° for nonsterilized and sterilized membranes, respectively, indicating consistent hydrophobicity. Thermal analyses confirmed the structural stability of PCL membranes, while UV–Vis studies validated their controlled degradation and release kinetics. FTIR and Raman spectroscopy confirmed that ozone sterilization preserved the chemical integrity of the membranes, with no new organic functions observed. Biocompatibility assays demonstrated high cell viability (> 97%) and effective adhesion on the membranes, highlighting their compatibility and suitability for supporting cell proliferation. These results demonstrate the efficacy of ozone sterilization and the potential of electrospun PCL membranes for a wide range of biomedical applications, including tissue engineering, wound healing, and drug delivery systems.

12 September 2017 in bioRxiv
Verified
Preprint
Open access
PDF file
TSThiago Moreira da Silva
Thiago Moreira da Silva
CPCarlos Danniel Pinheiro
Carlos Danniel Pinheiro
POPatrícia Orlandi
Patrícia Orlandi
CPCarlos Cleomir Pinheiro
Carlos Cleomir Pinheiro
GPgemilson pontes
gemilson pontes
Background: Essential oil obtained from rhizomes of the Zingiber zerumbet (L.) Smith (popularly known in Brazil as bitter ginger) is mainly constituted by the biomolecule zerumbone, which exhibit untapped antimicrobial potential. The aim of this study was to investigate the antimicrobial activity of the zerumbone from bitter ginger rhizomes against the cariogenic agent Streptococcus mutans. Methods: Firstly, the essential oil from rhizomes of Zingiber zerumbet (L.) Smith extracted by hydrodistillation was submitted to purification and recrystallization process to obtain the zerumbone compound. The purity of zerumbone was determined through high-performance liquid chromatography analysis. Different concentrations of zerumbone were tested against the standard strain S. mutans (ATCC 35668) by using microdilution method. The speed of cidal activity was determined through a time kill-curve assay. The biological cytotoxicity activity of zerumbone was assessed using Vero Cell line through MTT assay. Results: The zerumbone showed a minimum inhibitory concentration (MIC) of 250μg/ mL and a minimum bactericidal concentration (MBC) of 500μg/mL against S. mutans. After six hours of bacteria-zerumbone interaction, all concentrations tested starts to kill the bacteria and all bacteria were killed between 48 and 72 hours period at the concentration of 500μg/ mL (99,99% of bacteria were killed in comparison with original inoculum). In addition, zerumbone showed no cytotoxicity activity on mammalian continuous cells line. Conclusions: These results draw attention to the great potential of zerumbone as antimicrobial agent against S. mutans infection, indicating its possible use in the phyto-pharmaceutical formulations as new approach to prevent and treat tooth decay disease.

1 November 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
PSPaula Taquita Serra
Paula Taquita Serra
JVJoão Victor Verçosa
João Victor Verçosa
RSRuth Moura de Souza
Ruth Moura de Souza
PDPaloma Inessa de Souza Dantas
Paloma Inessa de Souza Dantas
ARAlan de Oliveira Rezende
Alan de Oliveira Rezende
POPatrícia Orlandi
Patrícia Orlandi
Background: Among Shigella species, Shigella boydii has always displayed a smaller role to the overall Shigella burden, frequently placed at third in epidemiological studies and described as restricted to Southeast Asia. Here we characterize an S. boydii isolated from an epidemiological study enrolling 1,339 Brazilian children from the Amazon region, in which Shigella species solely was the fourth cause of bacterial diarrhea. S. boydii strain 183 was isolated from rotavirus co-infected children with acute diarrhea. Here we aimed to characterize this strain regarding virulence and, immune response in a pulmonary model. Methods: An in vitro HEp-2 epithelial cell invasion assay was used to compare the invasive phenotype of S. boydii strain 183 with clinical and highly virulent S. flexneri strain, both isolated from Brazilian children. A murine pulmonary model was performed to assess lung damage by histopathological analysis. mRNA expression of immune response key genes was retrieved by multiplex real-time PCR and correlations were obtained by network analysis. Broad genome analysis was performed to confirm S. boydii identity and define its virulence profile. Results: S. boydii strain 183 showed fewer invasion rates in vitro and tissue damage in vivo as compared to virulent S. flexneri 201. When compared to a survival challenge in mice, S. boydii had 100% survival against 10% of virulent S. flexneri . Overall, mRNA immune gene expression suggests a protective response against S. boydii strains 183, in contrast to the inflammatory response induced by the virulent S. flexneri strain 201. Network analysis with S. boydii strain 183 displayed IFN-γ protagonism, contrasting with the correlations centralized on TNF-α by the virulent S. flexneri strain 201. The genome showed a lack of effector proteins and enterotoxins in S. boydii strain 183, and sequencing analysis of Ipa invasins revealed mutations at functional sites. This avirulent S. boydii strain 183 presents the Type II Secretion System, T6SS, in addition to T3SS. Conclusions: In addition to causing no disease, S. boydii strain 183 lacks effector proteins and enterotoxins. The presence of T6SS additional secretion system could provide an advantage to establish this strain among commensal bacteria. AUTHOR SUMMARY: The Shigella genus is a human pathogen responsible to shigellosis and remains one of the significant causes of morbidity and mortality in children under five years old. This genus has four species, Shigella flexneri , Shigella sonnei , Shigella boydii , and Shigella dysenteriae . S. flexneri and S. sonnei are the most common in the worldwide infections; S. dysenteriae is rarely found, and S. boydii is responsible for 1% of the infections and is known to be restricted to Southeast Asia. Once S. boydii have a relatively small role in global Shigella disease, there are few studies regarding its virulence and mechanisms. Here we characterize an S. boydii isolated from Brazilian children from the Amazon region, and aimed to describe this strain regarding virulence. It is known that Shigella species use the Type 3 Secretion System (T3SS) to invade and colonize the human intestine. We found in S. boydii the presence of Type 2 Secretion System (T2SS), Type 6 Secretion System (T6SS), in addition to the T3SS. The T6SS have been described in S. sonnei only, granting a competitive advantage against S. flexneri mixed cultures. The presence of T6SS additional secretion system could provide a benefit to establish this strain among commensal bacteria.